Protagonist Therapeutics Inc (PTGX)
Investing Cash Flow
-$2.43M
Quarterly · Period ending: · USD
PTGX Investing Cash Flow
Latest reported-$2.43Mperiod ending
Latest reported-$2.43Mperiod ending
PTGX Quarterly Cash from Investing (-$5.00K → -$2.43M)
Quarterly investing cash flow
High-resolution chart · PNG
PTGX investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -2,430,000 | |
| 90,892,000 | |
| 48,815,000 | |
| -58,555,000 | |
| 54,810,000 | |
| -94,402,000 | |
| -8,725,000 | |
| -208,710,000 | |
| -88,119,000 | |
| 6,071,000 | |
| -61,287,000 | |
| -13,559,000 | |
| 25,762,000 | |
| 9,826,000 | |
| 3,935,000 | |
| 57,275,000 | |
| 34,734,000 | |
| -4,476,000 | |
| 27,867,000 | |
| -44,707,000 | |
| 7,773,000 | |
| -6,793,000 | |
| -74,402,000 | |
| -54,122,000 | |
| -5,171,000 | |
| 42,730,000 | |
| -12,554,000 | |
| -32,039,000 | |
| -13,225,000 | |
| 4,108,000 | |
| 4,549,000 | |
| 9,917,000 | |
| 9,591,000 | |
| -21,844,000 | |
| 4,752,000 | |
| -772,000 | |
| 13,093,000 | |
| -1,250,000 | |
| -64,325,000 | |
| 3,884,000 | |
| -6,034,000 | |
| 7,147,000 | |
| -8,085,000 | |
| -113,000 | |
| -61,000 | |
| -5,000 |